Taymour has over 17 years working in the clinical research field and is currently a Global Studies Leader at Hoffmann-La Roche, a prominent multinational pharmaceutical company. He is responsible for leading cross-functional study teams on the successful execution and delivery of large global trials and overseeing a team of Global Studies Managers.

Previously, Taymour worked as a Global Studies Manager at Hoffmann-La Roche, where he was responsible for all operational aspects of study management and in various disease areas including infectious disease, immunology and ophthalmology. Prior to that, Taymour worked at multinational pharmaceutical firm Novo Nordisk Canada, as a Country Study Manager responsible for the management and execution of phase III-IV trials in diabetes, obesity and pediatrics. Taymour started his career working in Clinical Research Organizations. He held various roles including Senior Project Manager, Project Manager and Clinical Research Coordinator at AXON Clinical Research and DecisionLine Clinical Research.

Taymour has over 10 years of experience as an educator in the field of clinical research. He holds an Honours Bachelor of Science in Human Biology with a minor in Bioethics from the University of Toronto and a Post-Graduate Certificate in Clinical Research from Humber College.

Nicole has almost 20 years of Clinical Research experience working with several industry leaders in drug and vaccine development including Eli Lilly, PAREXEL and currently as an Associate Director and Clinical Trial Leader with EMD Serono Research & Development Institute Inc. In her experience in the multi-national pharmaceutical/biotech industry, Nicole has gained significant experience in managing programs and studies in Phase I through IV in therapeutic areas that include oncology, immunology, endocrinology, men’s and women’s health, central nervous system (CNS), infectious disease and vaccines.

Starting as a Local Study Manager in Canada managing Phase II and III studies, Nicole progressed through various roles and responsibilities which led to relocating to Geneva, Switzerland managing early development studies. Upon returning to Canada, Nicole further diversified her experience by joining Sanofi-Aventis, working on vaccine studies in Toronto. Over the last 10 years, Nicole has managed a number of programs with a focus on budgeting and procurement within a Clinical Trial Program environment.

Nicole obtained an Honours Bachelor of Science in Biology from The University of Western Ontario and a Certificate in Clinical Research from Humber College.

Jasmine is a Clinical Research Manager, Lead Research Training Program – Education Specialist across UHN Clinical Research at the Princess Margaret Cancer Program. She is responsible for developing and facilitating training programs based on clinical research staff needs and audit findings. Her projects include the standardization of clinical research documentation, quality assurance initiatives and establishing e-learning clinical research course content for UHN Research and the Princess Margaret Cancer Program. Jasmine also has over 15 years of experience working as a Study Coordinator, monitoring and coordinating multicentre investigator-initiated and sponsored oncology trials at Princess Margaret.

In 2013, Jasmine completed her Master’s degree in Adult Education and Community Development at the Ontario Institute for Studies in Education at the University of Toronto. Jasmine is a Professor in the School of Biological Sciences and Applied Chemistry at Seneca College and has designed and delivered training in clinical research practice and clinical trial project management at the Ontario Institute for Cancer Research (OICR) and University Health Network. Jasmine is an active member of SOCRA and since 2021 she has been the Co-Chair of the Education Committee with Network of Networks, a Canadian not for profit aimed at improving site quality and excellence in clinical trial conduct.

Amin brings nearly 25 years of experience in the pharmaceutical industry in all phases of pharmaceutical research and drug development. Amin has more than two decades of senior leadership, project management and clinical trial monitoring experience working across a broad spectrum of pharmaceutical companies, contract research organizations, and site management organizations. He has worked for Fortune 500 companies including Procter & Gamble, Amgen, Bristol Myers Squibb, Eli Lilly, Syneos, PPD, ICON, and Parexel. His experience includes operational oversight of multi-therapeutic, global Phase I-IV drug/biologic trials, device studies, and functional outcome projects. He has managed multi-compound client portfolios and programs for key accounts including a large Phase III global study with 3000+ patients from 180 sites across 26 countries where he oversaw global clinical operations and program management for Canada, USA, and Latin America.

In his current role as Director of Clinical Operations for Parexel Biotech, Inc., Amin focuses on end-to-end program management of large global Phase II/III oncology and rare disease studies. He works with global cross-functional teams to craft program strategy, mission, and vision, manage trial and department budgets and P&L functions, develop clinical and business decision support systems, and provide consulting services to clients.

Amin is also a licensed compounding pharmacist and provides direct patient care services in community pharmacy. Amin received his HBSc. in Cell & Molecular Biology, and a professional degree in Pharmacy (BPharm) from the University of Toronto, an MBA in Corporate Finance and Entrepreneurship from Queen’s University, and a Certificate in Precision Oncology and Cancer Genomics from the Harvard School of Medicine.

Miran has over 12 years of experience in clinical research, conducting academic and industry sponsored clinical trials in oncology, cardiology, and neuropsychopharmacology, following his completion of a PhD in molecular medicine (pharmacology). As a Scientific Associate with the Surgical Oncology Department of the Princess Margaret Cancer Centre, the largest oncology hospital in Canada and a global leader in cancer research, he supervised the conduct of a number of phase II and III clinical trials evaluating novel disease biomarkers and treatments.

In his current position as Research Manager within the Joint Department of Medical Imaging, Miran oversees research conducted using imaging modalities at University Health Network, Mt. Sinai Hospital, and Women’s College Hospital. He has extensive experience in the design and conduct of multi-site phase III studies and adaptive clinical trials accruing in both Canada and the United States.

Lisa has more than 15 years of clinical research experience gained in several multinational pharmaceutical companies, with a rapid growth of responsibilities. Currently, she is a Global Clinical Trial Manager at Janssen Inc., part of the Pharmaceutical Companies of Johnson and Johnson. She works with diverse cross-functional study teams including those at the global and country level and is responsible for the end-to-end operational management and delivery of large oncology trials.

Lisa has held a number of different roles in her career including Local/Country Trial Manager, Global Clinical Project Leader, Clinical Trial Monitor, Monitor Manager, and Study Coordinator. She has been an integral part of managing and leading teams to successful execution and delivery of Phase I-IV studies in various therapeutic areas, which includes oncology, endocrinology, immunology, cardiovascular, hematology, and neurology. Her extensive experience includes working at several prominent companies and academic institutions, such as Bayer Inc., Novo Nordisk Canada Inc., ApoPharma Inc., and Princess Margaret Cancer Centre.

Lisa holds an Honours Bachelor of Health Science from the University of Western Ontario and a Post-Graduate Certificate in Clinical Research. She is also a graduate of the Project Management Certificate Program at Ryerson University.

Taymour has over 17 years working in the clinical research field and is currently a Global Studies Leader at Hoffmann-La Roche, a prominent multinational pharmaceutical company. He is responsible for leading cross-functional study teams on the successful execution and delivery of large global trials and overseeing a team of Global Studies Managers.

Previously, Taymour worked as a Global Studies Manager at Hoffmann-La Roche, where he was responsible for all operational aspects of study management and in various disease areas including infectious disease, immunology and ophthalmology. Prior to that, Taymour worked at multinational pharmaceutical firm Novo Nordisk Canada, as a Country Study Manager responsible for the management and execution of phase III-IV trials in diabetes, obesity and pediatrics. Taymour started his career working in Clinical Research Organizations. He held various roles including Senior Project Manager, Project Manager and Clinical Research Coordinator at AXON Clinical Research and DecisionLine Clinical Research.

Taymour has over 10 years of experience as an educator in the field of clinical research. He holds an Honours Bachelor of Science in Human Biology with a minor in Bioethics from the University of Toronto and a Post-Graduate Certificate in Clinical Research from Humber College.

Nicole has almost 20 years of Clinical Research experience working with several industry leaders in drug and vaccine development including Eli Lilly, PAREXEL and currently as an Associate Director and Clinical Trial Leader with EMD Serono Research & Development Institute Inc. In her experience in the multi-national pharmaceutical/biotech industry, Nicole has gained significant experience in managing programs and studies in Phase I through IV in therapeutic areas that include oncology, immunology, endocrinology, men’s and women’s health, central nervous system (CNS), infectious disease and vaccines.

Starting as a Local Study Manager in Canada managing Phase II and III studies, Nicole progressed through various roles and responsibilities which led to relocating to Geneva, Switzerland managing early development studies. Upon returning to Canada, Nicole further diversified her experience by joining Sanofi-Aventis, working on vaccine studies in Toronto. Over the last 10 years, Nicole has managed a number of programs with a focus on budgeting and procurement within a Clinical Trial Program environment.

Nicole obtained an Honours Bachelor of Science in Biology from The University of Western Ontario and a Certificate in Clinical Research from Humber College.

Rob has practised Research Administration for over 25 years, presently as the Senior Director, Research Operations and Therapeutic Innovation with the Ontario Institute for Cancer Research (OICR), a collaborative, not-for-profit research institute focused on accelerating the translation of new cancer research discoveries to patients around the world. Since joining OICR in 2012, Rob has held leadership positions in Research Operations, Therapeutic Innovation, Genome Technologies, and Commercialization.

Previously, Rob worked at the Eli Lilly and Company headquarters in Indiana for 13 years and at Lilly’s Canadian affiliate for 4 years in various functional disciplines including clinical operations, strategy, governance, portfolio management, and research operations roles in preclinical and early clinical development. Rob provided strategic and operational leadership in medicinal chemistry, discovery-phase biotechnology and drug development, and across multiple therapeutic areas including oncology, endocrine, inflammation and neuroscience.

Rob completed his Bachelor of Science and Doctorate degrees in Physiology at the University of British Columbia. He continued with his post-doctoral training at the Banting and Best Diabetes Centre at the University of Toronto in Molecular Endocrinology. Robert also holds six sigma black belt certification.

Netal has over 16 years of progressive experience in the Clinical Research and Pharmaceutical domains. Netal is presently the Vice President of Clinical Operations for Novum Pharmaceutical Research Services, one of the world’s leading Contract Research Organizations. Previously, Netal held senior roles in medical services, clinical trials management, scientific and regulatory affairs and operations with multinational organizations that include Lambda Therapeutic Research where he served as the Director and then Vice President of Operations, and Intas Pharmaceuticals where he held the position of Senior Executive, Medical Services.

Netal brings research expertise in the design and management of early and late phase clinical research studies globally in various therapeutic areas including oncology, psychiatry, gastro-enterology, diabetes, and skin diseases. He has extensive regulatory interaction experience with the major regulatory authorities such as USFDA, Health Canada, MHRA, ANSM, and SCC.

Netal is a Doctor of Medicine (Pharmacology) and holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from M S University in India. He is a Certified Clinical Research Professional (CCRP) with the Society of Clinical Research Associates (SOCRA).

Ronak has over 14 years of experience working in the clinical research industry in Canada and India. He is currently a Global Study Manager (Oncology) at AstraZeneca Canada, where he is responsible for study management and delivery of clinical studies from clinical study protocol development through to study set-up, maintenance, close out, report development and archiving.

Ronak has extensive experience in the monitoring of clinical trials through early and late development (Phases I-IV) in various therapeutic areas, which includes oncology and cardiovascular in addition to endocrinology, ophthalmology and pain management. Ronak gained his monitoring experience as a Senior Clinical Research Associate with ICON-DocsGlobal, one of the world’s largest clinical research organizations, as well as a host of multinational pharmaceutical companies including Johnson & Johnson, Pfizer and Boehringer-Ingelheim across Canada and India.

Ronak is a Dentist by education and has a Post-Graduate Certificate in Clinical Research. He has certifications in Clinical Research and Clinical Research Project Management through the Association of Clinical Research Professionals (ACRP).

Mariana joined multinational pharmaceutical company GlaxoSmithKline (GSK) over 17 years ago in the Canadian clinical operations team, holding roles of increasing responsibility in study delivery at the regional and global levels in Latin America, Asia Pacific, the Middle East and North Africa, working on high profile clinical trials across multiple therapy areas and managing a team of Global Study Managers.

Mariana has worked on various process design and simplification initiatives in clinical operations and R&D Pharma. When two new strategic CROs were selected for the delivery of full-service outsourced studies, Mariana led a large network of GSK and CRO subject matter experts to collaboratively design and document an end-to-end outsourcing process. Mariana has supported GSK’s key strategic global relationships with PPD, PAREXEL, Q2 and Covance, with an active role in operational governance and oversight. Most recently, she held the position of Director, Third Party Risk and Oversight supporting teams in Clinical Operations, Medical, Real World Evidence, and Regulatory to reduce the outsourcing risk across R&D Pharma.

Mariana holds an Honours Bachelor of Science degree in Chemistry, a Masters in Biotechnology, is a Project Management Professional (PMP) and Lean Six Sigma Black Belt (LSSBB).

Lisa has over 15 years’ experience in research administration, knowledge translation and education in academic health science settings. An exceptional corporate change agent, Lisa has driven development in the strategic and functional capacity necessary to optimize success in clinical research. She has developed both corporate and divisional strategic plans, led teams through the completion of large strategic projects, and implemented operational systems and procedures to support the effective management of the research enterprise.

Over the course of her career, Lisa has facilitated research integration and scientific literacy across healthcare, legal and academic settings. She has held senior research administration positions at Baycrest Health Sciences, the Rotman Research Institute and The Hospital for Sick Children. Lisa has provided scientific communications expertise to organizations such as the Centre of Forensic Sciences in Toronto and the Molecular Diagnostics Laboratory at The Hospital for Sick Children, and is co-author of an authoritative manual on the use of DNA evidence in the judicial system. She also brings over 10 years’ experience teaching students at the secondary and post-secondary levels.

Lisa received her Ph.D. in cognitive psychology from York University, and was a Canadian Institutes of Health Research (CIHR) Postdoctoral Fellow in the Program in Neurosciences and Mental Health at The Hospital for Sick Children.

Tracy has over 20 years of experience in clinical research with organizations including the Hospital for Sick Children, the University Health Network, GlaxoSmithKline, and Janssen Canada. Currently, Tracy works for Janssen Canada, the pharmaceutical division of Johnson & Johnson, where she is responsible for all aspects of operational planning and oversight of Phase II-III drug trials in oncology, primarily in prostate cancer. She is also leading the implementation of Johnson & Johnson’s first CAR-T clinical trial program for multiple myeloma in Canada.

Previously, Tracy worked at GSK as a Medical Research Manager, operationalizing all aspects of global and local investigator-initiated studies in therapeutic areas including HIV, oncology and rheumatology. She was awarded the GSK North American Medical Affairs award for uncovering a compliance issue with an international CRO. Tracy started her clinical research career in metabolic genetics, managing trials for rare diseases such as Fabry disease, Neiman-Pick, MPS-I & MPS-II.

Tracy holds a Bachelor of Science degree in Neurosciences from the University of Toronto, a diploma in Nuclear Medicine from the Michener Institute for Applied Health Sciences and is a Certified Clinical Research Professional (CCRP) with the Society of Clinical Research Associates (SOCRA). She is currently completing her MBA at the Jack Welch Management Institute. Tracy has also served as a Board Member of the Mount Sinai Hospital Research Ethics Board.

Nadia has more than 25 years of experience in clinical development, including strategic roles centered on quality and operational productivity. The foundation of her career was in Clinical Project Management, working at local, regional and global levels for several top pharmaceutical companies including GlaxoSmithKline, Eli Lilly and Company and Parke-Davis, a subsidiary of Pfizer. Presently, Nadia is contributing to drug development in the emerging CRO sector of the healthcare industry. In Program Management with ICON Strategic Solutions, she has led the transition, implementation and oversight of large-scale strategic partnerships, collaborating with large pharmaceutical and biotech companies to ensure the delivery and quality of global, cross-functional service provider programs.  In her current role as North America Regional Head, she continues to build and ensure the delivery of operational excellence in Program Management across the region.

Throughout her career, Nadia has enjoyed sharing her passion for clinical research in training and teaching opportunities. Her work in building a clinical research training program for graduates of the Masters of Biotechnology program at GSK in collaboration with the University of Toronto earned her the Mississauga Board of Trade Business Award of Excellence for Nurturing Success: Education & Business Working Together. She has also applied her expertise in clinical research as an Adjunct Professor at Humber College in the School of Health Sciences for the post-graduate Clinical Research Certification Program. Nadia holds an Honours Bachelor of Science from the University of Toronto, with a specialization in Toxicology.

Julie Szirtes leads the Clinical Research & Development function of Apotex Inc., a Canadian pharmaceutical company with global presence, which develops mainly generic products. Over the last 18 years working in the pharmaceutical industry, Julie has accumulated expertise in the planning, design, conduct and interpretation of bioavailability / bioequivalence pharmacokinetic studies in both healthy and patient populations, for products intended to be registered in numerous global markets. She has been involved in clinical studies on products covering a vast array of therapeutic areas, and a wide variety of dosage forms including small molecule oral solids and liquids, transdermal products, inhalation products, nanoparticle medicines, and large molecule biological products. Julie’s main responsibility is to provide scientific expertise and strategic direction in the design and analysis of bioequivalence studies developed by Apotex. She has overseen scientists, statisticians, data managers, technical writers and project managers involved in the planning and analysis of several hundreds of bioequivalence studies.
Julie received her HBSc. in Physiology and M.Sc. in Pharmaceutical Sciences from the University of Toronto in 2003, where the focus of her research was evaluating alterations in CYP 450 enzymes and P-glycoprotein and the associated impact on drug absorption through the gastrointestinal tract in the presence of inflammatory processes and diseases.